ATE281460T1 - Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung - Google Patents

Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung

Info

Publication number
ATE281460T1
ATE281460T1 AT97900933T AT97900933T ATE281460T1 AT E281460 T1 ATE281460 T1 AT E281460T1 AT 97900933 T AT97900933 T AT 97900933T AT 97900933 T AT97900933 T AT 97900933T AT E281460 T1 ATE281460 T1 AT E281460T1
Authority
AT
Austria
Prior art keywords
pyrido
thiadiazine
production
thiazine derivatives
compounds
Prior art date
Application number
AT97900933T
Other languages
English (en)
Inventor
Bernard Pirotte
Philippe Lebrun
Tullio Pascal De
Fabian Somers
Jacques Elie Delarge
Holger Claus Hansen
Flemming Elmelund Nielsen
John Bondo Hansen
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Application granted granted Critical
Publication of ATE281460T1 publication Critical patent/ATE281460T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
AT97900933T 1996-01-17 1997-01-16 Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung ATE281460T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK4296 1996-01-17
DK24996 1996-03-05
DK24896 1996-03-05
DK24796 1996-03-05
DK24696 1996-03-05
PCT/DK1997/000018 WO1997026264A1 (en) 1996-01-17 1997-01-16 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE281460T1 true ATE281460T1 (de) 2004-11-15

Family

ID=27512741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900933T ATE281460T1 (de) 1996-01-17 1997-01-16 Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung

Country Status (16)

Country Link
US (1) US5792764A (de)
EP (1) EP0877748B1 (de)
JP (1) JP2000503651A (de)
KR (1) KR19990077320A (de)
CN (1) CN1208418A (de)
AT (1) ATE281460T1 (de)
AU (1) AU727905B2 (de)
BR (1) BR9707004A (de)
CA (1) CA2241565A1 (de)
CZ (1) CZ220598A3 (de)
DE (1) DE69731458T2 (de)
IL (1) IL125072A (de)
NO (1) NO983285L (de)
PL (1) PL327927A1 (de)
RU (1) RU2193564C2 (de)
WO (1) WO1997026264A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329368B1 (en) * 1997-05-09 2001-12-11 The Regents Of The University Of California Endocrine modulation with positive modulators of AMPA type glutamate receptors
WO1999032495A1 (en) * 1997-12-19 1999-07-01 Novo Nordisk A/S Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
AU2001265840A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel agonists for reducing fat food comsumption
AU2002342600A1 (en) * 2001-11-30 2003-06-10 Novo Nordisk A/S Use of selective potassium channel openers
US20030109519A1 (en) * 2001-11-30 2003-06-12 Jeppe Sturis Use of selective potassium channel openers
WO2003045955A1 (en) * 2001-11-30 2003-06-05 Novo Nordisk A/S Use of selective potassium channel openers
WO2003105896A1 (en) * 2002-06-14 2003-12-24 Novo Nordisk A/S Combined use of a modulator of cd3 and a beta cell resting compound
WO2013191984A1 (en) * 2012-06-21 2013-12-27 Boehringer Ingelheim International Gmbh Fused thiazin-3-ones as kca3.1 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
FR2650589A1 (fr) * 1989-08-04 1991-02-08 Esteve Labor Dr Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments
FR2703051B1 (fr) * 1993-03-26 1995-04-28 Adir Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NO983285L (no) 1998-09-16
NO983285D0 (no) 1998-07-16
JP2000503651A (ja) 2000-03-28
EP0877748B1 (de) 2004-11-03
AU727905B2 (en) 2001-01-04
EP0877748A1 (de) 1998-11-18
CN1208418A (zh) 1999-02-17
CZ220598A3 (cs) 1998-12-16
KR19990077320A (ko) 1999-10-25
IL125072A0 (en) 1999-01-26
US5792764A (en) 1998-08-11
CA2241565A1 (en) 1997-07-24
IL125072A (en) 2002-12-01
DE69731458D1 (de) 2004-12-09
BR9707004A (pt) 1999-07-20
PL327927A1 (en) 1999-01-04
AU1437097A (en) 1997-08-11
DE69731458T2 (de) 2005-12-22
WO1997026264A1 (en) 1997-07-24
RU2193564C2 (ru) 2002-11-27

Similar Documents

Publication Publication Date Title
DE69908648D1 (de) Kondensierte 1,2,4-thiadiazinderivate, ihre herstellung und verwendung
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
DE3576331D1 (de) Tetralin-derivate, ihre herstellung und verwendung.
CA2157117A1 (en) Spirocyclic Piperidine Derivatives
DE69817802D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE69727806D1 (de) 1,2,4-benzothiadiazin-derivate, ihre herstellung und verwendung
DE69819173D1 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
ATE51622T1 (de) Beta-carbolin-3-oxadiazolylderivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE281460T1 (de) Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung
FI102174B1 (fi) Menetelmä 1,2,3,4-tetrahydro- ja 1,2,3,3a,4,8b-heksahydrosyklopent[b]indolijohdannaisten valmistamiseksi
DE3765853D1 (de) Hydroxipyrazol-derivate- verfahren zu ihrer herstellung und ihre verwendung gegen mikroorganismen.
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE69514532D1 (de) Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DE59901563D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ATE73767T1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE24487T1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE42284T1 (de) Unsymmetrische dihydro-dithiazine, verfahren zu ihrer herstellung und ihre verwendung als riech- und geschmacksstoffe.
DE59905342D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater
ATE33020T1 (de) 10,11-dihydro-5h-dibenzo(a,d>cycloheptadienderivate, ihre herstellung und verwendung.
EP1148059A4 (de) Thiazolpyrimidin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0877748

Country of ref document: EP

REN Ceased due to non-payment of the annual fee